Further it was suggested that multiple autoimmune diseases, besides GD and rheumatoid arthritis, might share IGF-IR-dependent disease mechanisms and that therapeutic development could be successfully focused on that receptor (61). The gene discussed is IGF1R; the disease is rheumatoid arthritis.